AG
EVAR

Advisor Group’s Lombard Medical, Inc. EVAR Stock Holding History

Advisor Group’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,025
Closed -$8K – 4752
2016
Q3 		$8K Sell
9,025
-2,185
-19% -$2.32K ﹤0.01% 3722
2016
Q2 		$12K Buy
+11,210
New +$15.6K ﹤0.01% 3407

Other funds holding EVAR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisor Group's EVAR Position: Q4 2016 in Review

Advisor Group sold out of Lombard Medical, Inc. (EVAR) in Q4 2016, closing a stake of 9,025 shares — an estimated $8K sold.

Advisor Group first reported a position in EVAR in Q2 2016 and held it in 2 quarters. The position peaked at $12K in Q2 2016. 9 funds tracked by Wall St. Rank hold EVAR as of Q4 2016.

  • Advisor Group reported no remaining Lombard Medical, Inc. position as of Q4 2016 after selling out during the quarter.
  • Advisor Group sold 9,025 Lombard Medical, Inc. shares in Q4 2016, an estimated $8K.
  • Advisor Group first reported a position in Lombard Medical, Inc. in Q2 2016 and held it in 2 quarters.
  • Advisor Group's Lombard Medical, Inc. position peaked at $12K in Q2 2016.
  • 9 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2016.

Based on Advisor Group's 13F filing for Q4 2016, filed 31 Jan 2017.